Clinical immunotherapy in pancreatic cancer.

Authors:
Ye X; Yu Y; Zheng X; Ma H.

Journal:
Cancer Immunol Immunother

Publication Year: 2024

DOI:
10.1007/s00262-024-03632-6

PMCID:
PMC10908626

PMID:
38430289

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cancer Immunol Immunother

Abbreviation: Cancer Immunol Immunother

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram.
Zhang X; Sun R; Zhang M and 7 more (2024) - Transparency Score: 3/6
A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1…
Luo Y; Liu C; Yao Y and 5 more (2024) - Transparency Score: 3/6
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.
Gurrea-Rubio M; Wu Q; Amin MA and 16 more (2024) - Transparency Score: 3/6
Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenviro…
Zhu Q; Cao Y; Yuan J and 1 more (2024) - Transparency Score: 3/6
A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma pa…
Wu YX; Tian BY; Ou XY and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (#82171783, # 81871284, # 82241216, # 32270963, # 31870993), Research Funds of Center for Advanced Interdisciplinary Science and Biomedicine of IHM (Reference Numbers: QYZD20220008), Anhui key research and development plan (Reference Numbers: 2023z04020011), and the Fundamental Research Funds for the Central Universities (WK9110000005)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025